Immunochromatography kit for bone marker detection and preparation method thereof
An immunochromatography and marker technology, applied in measurement devices, analytical materials, instruments, etc., can solve the problems of lack of sensitivity and timeliness in the evaluation of osteoporosis treatment effects, and achieve high detection sensitivity, simple operation, and ease of use. control effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0047] The kit for detection of bone markers in this embodiment includes a plastic plate, a glass cellulose membrane set on the plastic plate, a nitrocellulose membrane set on the glass cellulose membrane, and a sample is arranged at one end of the nitrocellulose membrane. The corresponding other end is provided with a water-absorbing pad, and the glass cellulose membrane is coated with quantum dot-labeled type I collagen carboxy-terminal peptide (CTX) antibody at a mass ratio of 1:1:1, quantum dot-labeled bone A mixture of calcein (OC) antibody and quantum dot-labeled type I procollagen amino-terminal propeptide (PINP) antibody; the nitrocellulose membrane is provided with a detection line 1, a detection line 2, a detection line 3 and a control line, The detection line 1 is coated with type I collagen carboxy-terminal peptide (CTX) secondary antibody, the detection line 2 is coated with osteocalcin (OC) secondary antibody, and the detection line 3 is coated with type I collage...
Embodiment 2
[0058] The kit for detecting bone markers in this example differs from the example in that the quantum dots used are cadmium sulfide quantum dots, the modified cyclodextrin used is aminated dry cyclodextrin, and the type I collagen carboxyl In the process of peptide-terminal (CTX) antibody, quantum dot-labeled osteocalcin (OC) antibody and quantum dot-labeled type Ⅰ procollagen N-terminal propeptide (PINP) antibody, the activated quantum dot-modified cyclodextrin -The mixing time for adding the antibody or antigen to the latex suspension is 2 hours, and the others are the same as in Example 1.
Embodiment 3
[0060] The kit for detection of bone markers in this example differs from the example in that the type I collagen carboxy-terminal peptide (CTX) antibody, the quantum dot-labeled osteocalcin (OC) antibody and the quantum dot-labeled type I protoplast During the process of the collagen amino-terminal propeptide (PINP) antibody, the mixing time of adding the antibody or antigen to the activated quantum dot-modified cyclodextrin-latex suspension was 4 hours, and the others were the same as in Example 1.
PUM
![No PUM](https://static-eureka.patsnap.com/ssr/23.2.0/_nuxt/noPUMSmall.5c5f49c7.png)
Abstract
Description
Claims
Application Information
![application no application](https://static-eureka.patsnap.com/ssr/23.2.0/_nuxt/application.06fe782c.png)
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com